The estimated Net Worth of Shelly Ramasamy Selvaraj is at least $12.7 Million dollars as of 15 June 2023. Mr. Selvaraj owns over 2,115 units of Dexcom Inc stock worth over $3,450,203 and over the last 5 years he sold DXCM stock worth over $9,219,072. In addition, he makes $0 as Senior Vice President - Information Technology at Dexcom Inc.
Sign up
Mr. Selvaraj DXCM stock SEC Form 4 insiders trading
Shelly has made over 16 trades of the Dexcom Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 2,115 units of DXCM stock worth $274,950 on 15 June 2023.
The largest trade he's ever made was selling 4,567 units of Dexcom Inc stock on 10 March 2021 worth over $1,644,257. On average, Shelly trades about 1,225 units every 54 days since 2020. As of 15 June 2023 he still owns at least 50,390 units of Dexcom Inc stock.
You can see the complete history of Mr. Selvaraj stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Shelly Selvaraj biography
Shelly R. Selvaraj serves as Senior Vice President - Information Technology of the Company. He has served as our Senior Vice President, Information Technology since October 2018, and previously served as our Vice President, Information Technology from May 2016 to October 2018. Mr. Selvaraj has a wide range of experience within global organizations in the fields of supply chain management, healthcare informatics and information technology. Prior to joining Dexcom, Mr. Selvaraj held various IT leadership roles at CareFusion, a Becton Dickinson Company, from March 2012 to May 2016, and ResMed in San Diego from April 2007 to March 2012. Earlier in his career, he worked for Motorola, Inc. and ON Semiconductor Corp. in Phoenix, Arizona. Mr. Selvaraj received a BE in Mechanical Engineering from the University of Madras and a Masters in Industrial Engineering from Arizona State University.
How old is Shelly Selvaraj?
Shelly Selvaraj is 61, he's been the Senior Vice President - Information Technology of Dexcom Inc since 2018. There are 9 older and 19 younger executives at Dexcom Inc. The oldest executive at Dexcom Inc is Andrew K. Balo, 73, who is the Exec. VP of Regulatory Strategy, Clinical Affairs & Strategic Partnership Devel..
What's Shelly Selvaraj's mailing address?
Shelly's mailing address filed with the SEC is 6340, Sequence Drive, Sorrento Valley, San Diego, San Diego County, California, 92121, United States.
Insiders trading at Dexcom Inc
Over the last 19 years, insiders at Dexcom Inc have traded over $724,717,982 worth of Dexcom Inc stock and bought 165,450 units worth $3,489,100 . The most active insiders traders include Sean Carney, Kim D Blickenstaff, and Steven R Altman. On average, Dexcom Inc executives and independent directors trade stock every 7 days with the average trade being worth of $892,438. The most recent stock trade was executed by Sadie Stern on 9 September 2024, trading 426 units of DXCM stock currently worth $29,458.
What does Dexcom Inc do?
founded in 1999, dexcom, inc provides continuous glucose monitoring technology to help patients and their clinicians better manage diabetes. since our inception, we have focused on better outcomes for patients, caregivers, and clinicians by delivering solutions for people with diabetes — while empowering our community to take control of diabetes.
What does Dexcom Inc's logo look like?
Complete history of Mr. Selvaraj stock trades at Dexcom Inc
Dexcom Inc executives and stock owners
Dexcom Inc executives and other stock owners filed with the SEC include:
-
Kevin Sayer,
Chairman of the Board, President, Chief Executive Officer -
Quentin Blackford,
Chief Financial Officer, Chief Operating Officer -
Richard Doubleday,
Executive Vice President, Chief Commercial Officer -
Andrew Balo,
Executive Vice President - Regulatory Strategy, Clinical Affairs, and Strategic Partnership Development -
Steven Pacelli,
Executive Vice President - Strategy and Corporate Development -
Donald Abbey,
Executive Vice President - Quality and Regulatory Affairs -
Kevin Ronald Sayer,
Exec. Chairman, CEO & Pres -
Jacob Steven Leach,
Exec. VP & CTO -
Bridgette Heller,
Independent Director -
Mark Foletta,
Lead Independent Director -
Eric Topol,
Independent Director -
Jay Skyler,
Independent Director -
Nicholas Augustinos,
Independent Director -
Steven Altman,
Independent Director -
Barbara Kahn,
Independent Director -
Richard Collins,
Independent Director -
Kyle Malady,
Independent Director -
Karen Dahut,
Independent Director -
Shelly Selvaraj,
Senior Vice President - Information Technology -
Jeffrey Moy,
Senior Vice President - Operations -
Jereme Sylvain,
Senior Vice President - Finance, Chief Accounting Officer -
Patrick Murphy,
Executive Vice President, Chief Legal Officer -
Jake Leach,
Executive Vice President, Chief Technology Officer -
Shelly Ramasamy Selvaraj,
Sr. VP of Information Technology -
Donald M. Abbey,
Exec. VP of Global Bus. Services, IT, Quality & Regulatory Affairs -
Steven R. Pacelli,
Exec. VP & MD of Dexcom Ventures -
Andrew K. Balo,
Exec. VP of Regulatory Strategy, Clinical Affairs & Strategic Partnership Devel. -
Sadie M. Stern,
Exec. VP & Chief HR Officer -
Chad M. Patterson,
Exec. VP of Global Marketing -
Sean Christensen,
Director of Corp. Affairs & Head of Investor Relations -
Jereme M. Sylvain,
Exec. VP, CFO & Chief Accounting Officer -
John Lister,
VP, Legal Affairs -
Terrance H Gregg,
Director -
Jess Roper,
VP, CFO -
Jorge A Valdes,
Vice President of Engineering -
Girish Naganathan,
EVP Chief Technology Officer -
Heather S Ace,
SVP Human Resources -
Kevin M Sun,
VP, Corp Controller & Treasury -
Jonathan T Md Lord,
Director -
Glen D Nelson,
Director -
Peter Gerhardsson,
VP, Int'l Business Development -
David Carner,
VP, Quality Assurance -
Laura Johnson,
V.P., Intellectual Property -
Martin Doordan,
Director -
Sean Carney,
Director -
John Riolo,
VP of Quality Assurance -
Claudia Graham,
VP, Marketing -
Donald A Lucas,
Director -
Donald L Lucas,
Director -
Mark Brister,
VP, Advanced Development Teams -
Richard Yang,
V.P., Strategic Affairs -
James H Brauker,
VP, Research & Development -
Rodney L Kellogg,
Vice President of Sales -
Andrew P Rasdal,
President and CEO -
Steven J Kemper,
Chief Financial Officer -
Kim D Blickenstaff,
Director -
Tae Andrews,
Vice President of Marketing -
Paul Travelers Companies In...,
-
Pincus Private Equity Viii ...,
-
Brenton Karl Ahrens,
Director -
Nancy Sfog City Management ...,
-
Equity Partners Ii Llccanaa...,
-
Paul Travelers Companies In...,
-
Eric A Charmers Landing Llc...,
-
Scott Lwindamere Llcwindame...,
-
Equity Partners Ii Llc Waub...,
-
Teri L Lawver,
EVP Chief Commercial Officer -
Paul R Flynn,
EVP Global Revenue -
Matthew Vincent Dolan,
EVP Strategy and Corporate Dev -
Sumi Shrishrimal,
SVP Chief Risk Officer -
Chad Patterson,
EVP Global Marketing -
Barry J. Regan,
EVP Operations -
Jacob Steven Leach,
EVP, Chief Operating Officer -
Rimma Driscoll,
Director -
Michael Jon Brown,
EVP, Chief Legal Officer -
Sadie Stern,
EVP, Chief HR Officer